Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Musculoskeletal
Disease Category: Multiple Sclerosis
Trial Information
New medicine for patients with Multiple Sclerosis experiencing Neuropathic Pain
Cymbalta in Patients with Central Neuropathic Pain Due to Multiple Sclerosis
This five month study is designed to study the effectiveness of Cymbalta compared to placebo in treating neuropathic pain due to Multiple Sclerosis.
Major Inclusion/Exclusion Criteria:
- Ages 18 and above
- Must be diagnosed with MS for at least one year
- Must experience chronic daily pain (from MS)
- May continue other analgesic medications if on stable dose
- May not be taking any anti-depressant medication
Alpine Clinical Research Center
1000 Alpine Avenue, Suite 200
Boulder, CO 80304
Phone: 303-443-7229 x108
EMail: deb@alpineresearch.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
